Zai picks up GSK inflammation candidates

Zai Lab Ltd. (Shanghai, China) said it gained exclusive, worldwide rights to two undisclosed candidates from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK). Both have applications in multiple anti-inflammatory indications, Zai said. ...